SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-041582
Filing Date
2019-08-26
Accepted
2019-08-26 07:30:39
Documents
14
Period of Report
2019-08-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv528204_8k.htm   iXBRL 8-K 45532
2 EXHIBIT 2.1 tv528204_ex2-1.htm EX-2.1 762558
  Complete submission text file 0001144204-19-041582.txt   1179646

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA celg-20190825.xsd EX-101.SCH 3687
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celg-20190825_def.xml EX-101.DEF 26499
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celg-20190825_lab.xml EX-101.LAB 35819
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celg-20190825_pre.xml EX-101.PRE 25136
7 EXTRACTED XBRL INSTANCE DOCUMENT tv528204_8k_htm.xml XML 5124
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34912 | Film No.: 191050478
SIC: 2834 Pharmaceutical Preparations